Literature DB >> 15001903

Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions.

Igor E Konstantinov1, John G Coles, Cathy Boscarino, Mark Takahashi, Jason Goncalves, Julia Ritter, Glen S Van Arsdell.   

Abstract

BACKGROUND: The global myocardial stress response during cardiac surgery has not been systematically studied, nor is it known whether the response of the neonatal myocardium is intrinsically different from that of older children. To determine the age-related molecular basis of this response, we conducted microarray-based differential gene expression profiling on right ventricular tissue samples acquired in patients of varying ages with right ventricular outflow tract obstruction.
METHODS: We studied gene expression profiles in 24 patients during operations for lesions involving right ventricular outflow tract obstruction age stratified into group I (7 patients, aged 5 to 66 days; mean, 30 days) and group II (17 patients, aged 4 months to 12.5 years; mean, 2.8 years). Myocardial samples were taken from the right ventricular outflow tract after aortic occlusion and archived in liquid nitrogen. RNA isolation, fluorescence labeling of complementary DNA, hybridization to spotted arrays containing 19,008 characterized or unknown human complementary DNAs, and quantitative fluorescence scanning of gene-expression intensity were performed at the University of Toronto Health Network Microarray Centre. Data were analyzed with the Significance Analysis for Microarrays program. Minimum Information About Microarray Experiments-compliant, log2-normalized data sets were compared to ascertain potential statistical differences in gene expression between patient groups.
RESULTS: There were no hospital deaths or major postoperative morbid events. We identified 50 transcripts differentially expressed in the neonatal group (the predicted false discovery rate was <0.8 transcripts). The neonatal pattern of gene expression (group I) was dominated by genes with literature-validated cardioprotective, antihypertrophic, and antiproliferative properties, including increases in atrial natriuretic peptide, protein phosphatase 2A, small GTPase rap1, and protein inhibitor of activated STAT protein, PIASy. Several transcripts have not been previously reported in heart.
CONCLUSIONS: Neonatal myocardium has a unique pattern of gene expression, which may result from developmental (age-related) differences or reflect a more severe disease phenotype independent of age effects per se. The neonatal transcript profile seems to reflect a stress-induced protective program composed of genes with functions diametrically opposed to those expected to be related to the pathogenesis of critical right ventricular outflow tract obstruction, thus revealing a novel and compensatory antidisease transcriptional response in the neonatal heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001903     DOI: 10.1016/j.jtcvs.2003.08.056

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery.

Authors:  Mohamed T Ghorbel; Myriam Cherif; Amir Mokhtari; Vito Domenico Bruno; Massimo Caputo; Gianni D Angelini
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

2.  Controlled reoxygenation cardiopulmonary bypass is associated with reduced transcriptomic changes in cyanotic tetralogy of Fallot patients undergoing surgery.

Authors:  Mohamed T Ghorbel; Amir Mokhtari; Maimuna Sheikh; Gianni D Angelini; Massimo Caputo
Journal:  Physiol Genomics       Date:  2012-09-18       Impact factor: 3.107

3.  Cardioprotective stress response in the human fetal heart.

Authors:  John G Coles; Cathy Boscarino; Mark Takahashi; Diane Grant; Astra Chang; Julia Ritter; Xiaojing Dai; Changqing Du; Gabriel Musso; Hideaki Yamabi; Jason Goncalves; Ashu Sunny Kumar; James Woodgett; Huanzhang Lu; Gregory Hannigan
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

4.  Pias1 is essential for erythroid and vascular development in the mouse embryo.

Authors:  Jerfiz D Constanzo; Mi Deng; Smita Rindhe; Ke-Jing Tang; Cheng-Cheng Zhang; Pier Paolo Scaglioni
Journal:  Dev Biol       Date:  2016-05-04       Impact factor: 3.582

5.  Gene expression in pediatric heart disease with emphasis on conotruncal defects.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; James E O'Brien; Gary K Lofland; Merlin G Butler
Journal:  Prog Pediatr Cardiol       Date:  2005-06-09

Review 6.  Heart failure in congenital heart disease: the role of genes and hemodynamics.

Authors:  Rachel D Vanderlaan; Christopher A Caldarone; Peter H Backx
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

7.  Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression.

Authors:  Mohamed T Ghorbel; Myriam Cherif; Emma Jenkins; Amir Mokhtari; Damien Kenny; Gianni D Angelini; Massimo Caputo
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-22       Impact factor: 5.209

8.  C3G overexpression in glomerular epithelial cells during anti-GBM-induced glomerulonephritis.

Authors:  Victoriya A Rufanova; Elias Lianos; Anna Alexanian; Elena Sorokina; Mukut Sharma; Ann McGinty; Andrey Sorokin
Journal:  Kidney Int       Date:  2008-09-10       Impact factor: 10.612

9.  Gene expression analysis in cardiac tissues from infants identifies candidate agents for Tetralogy of Fallot.

Authors:  Dicheng Yang; Jing Li; Zhongxiang Yuan
Journal:  Pediatr Cardiol       Date:  2013-04-07       Impact factor: 1.655

10.  Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans.

Authors:  Michele Hepponstall; Vera Ignjatovic; Steve Binos; Paul Monagle; Bryn Jones; Michael H H Cheung; Yves d'Udekem; Igor E Konstantinov
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.